Litigation Details for Vertex Pharmaceuticals Incorporated v. Lupin Limited (D. Del. 2022)
✉ Email this page to a colleague
Vertex Pharmaceuticals Incorporated v. Lupin Limited (D. Del. 2022)
| Docket | ⤷ Try a Trial | Date Filed | 2022-07-22 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
| Jury Demand | None | Referred To | |
| Parties | LUPIN PHARMACEUTICALS, INC. | ||
| Patents | 10,272,046; 8,883,206 | ||
| Attorneys | Jacob C. Britz | ||
| Firms | Morris, Nichols, Arsht & Tunnell | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Vertex Pharmaceuticals Incorporated v. Lupin Limited
The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial and ⤷ Try a Trial .
Details for Vertex Pharmaceuticals Incorporated v. Lupin Limited (D. Del. 2022)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2022-11-13 | 26 | Order | . 13. “Patents-in-suit” means U.S. Patent Nos. 8,883,206, 10,272,046, 10,646,481, and 11,147,770…current responsibility for the Patent Prosecution of any patent or patent application claiming priority…participate in or supervise any Patent Prosecution of any patent or patent application for ivacaftor, products… “Patent Prosecution” means direct participation or supervision in drafting or amending patent claims…the preparation or prosecution of any patent application, any patent office proceeding, any petitioning | External link to document |
| 2022-07-22 | 3 | Patent/Trademark Report to Commissioner of Patents | Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,883,206 B2 ;10,272,046 B2 ;10,646,… 22 July 2022 1:22-cv-00966 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
